Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 368(9537), 804–813 (2006).
  Medline CASGoogle Scholar
• 2 Masoli M, Fabian D, Holt S et al. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59(5), 469–478 (2004).
  MedlineGoogle Scholar
• 3 Knudsen TB, Thomsen SF, Nolte H et al. A population-based clinical study of allergic and non-allergic asthma. J. Asthma 46(1), 91–94 (2009).
  MedlineGoogle Scholar
• 4 Johnston SL, Pattemore PK, Sanderson G et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 310(6989), 1225–1229 (1995).
  Medline CASGoogle Scholar
• 5 Atmar RL, Guy E, Guntupalli KK et al. Respiratory tract viral infections in inner-city asthmatic adults. Arch. Intern. Med. 158(22), 2453–2459 (1998).
  Medline CASGoogle Scholar
• 6 Sigurs N, Gustafsson PM, Bjarnason R et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am. J. Respir. Crit. Care Med. 171(2), 137–141 (2005).
  MedlineGoogle Scholar
• 7 Sigurs N, Bjarnason R, Sigurbergsson F et al. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am. J. Respir. Crit. Care Med. 161(5), 1501–1507 (2000). • Supports the theory that the Respiratory syncytial virus (RSV) influences the mechanisms involved in the development of asthma and allergy in children.
  Medline CASGoogle Scholar
• 8 Stein RT, Sherrill D, Morgan WJ et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354(9178), 541–545 (1999).
  Google Scholar
• 9 Aeffner F, Davis IC. Respiratory syncytial virus reverses airway hyperresponsiveness to methacholine in ovalbumin-sensitized mice. PLoS ONE 7(10), e46660 (2012). •• Suggests that RSV induces keratinocyte cytokine-mediated activation of Gαi, resulting in cross-inhibition of Gαq-mediated M(3)-muscarinic receptor signaling and reversal of airway hyperresponsiveness.
  MedlineGoogle Scholar
• 10 Jia Wang, Lingwen Kong, Qingli Luo et al. Dual effects of respiratory syncytial virus infections on airway inflammation by regulation of Th17/Treg responses in ovalbumin-challenged mice. Inflammation 37(6), 1984–2005 (2014). •• Interesting data showing that RSV-induced respiratory infections could produce dual effects pertaining to allergic airway inflammation in ovalbumin-challenged mice.
  MedlineGoogle Scholar
• 11 Zhang L, Liu J, Wang E et al. Respiratory syncytial virus protects against the subsequent development of ovalbumin-induced allergic responses by inhibiting Th2-type γδ T cells. J. Med. Virol. 85(1), 149–156 (2013).
  Medline CASGoogle Scholar
• 12 Walker JA, Barlow JL, McKenzie ANJ. Innate lymphoid cells – how did we miss them? Nat. Rev. Immunol. 13(2), 75–87 (2013).
  Medline CASGoogle Scholar
• 13 Kabata H, Moro K, Koyasu S et al. Group 2 innate lymphoid cells and asthma. Allergol. Int. 64(3), 227–234 (2015). • Comprehensive review on group 2 innate lymphoid cells and their role in asthma.
  Medline CASGoogle Scholar
• 14 Barlow JL, Bellosi A, Hardman CS et al. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J. Allergy Clin. Immunol. 129(1), 191–198 (2012).
  Medline CASGoogle Scholar
• 15 Klein Wolterink RG, Kleinjan A, van Nimwegen M et al. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur. J. Immunol. 42(5), 1106–1116 (2012).
  MedlineGoogle Scholar
• 16 Reed L, Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27(3), 493–497 (1938).
  Google Scholar
• 17 Halim TY, Krauss RH, Sun AC et al. Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 36(3), 451–463 (2012).
  Medline CASGoogle Scholar
• 18 Bartemes KR, Iijima K, Kobayashi T et al. IL-33-responsive lineage-CD25⁺ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J. Immunol. 188(3), 1503–1513 (2012).
  Medline CASGoogle Scholar
• 19 Chang YJ, Kim HY, Albacker LA et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 12(7), 631–638 (2011).
  Medline CASGoogle Scholar
• 20 Gorski SA, Hahn YS, Braciale TJ. Group 2 innate lymphoid cell production of IL-5 is regulated by NKT cells during influenza virus infection. PLoS Pathog. 9(9), e1003615 (2013).
  Medline CASGoogle Scholar
• 21 Beamer CA, Girtsman TA, Seaver BP et al. IL-33 mediates multi-walled carbon nanotube (MWCNT)-induced airway hyper-reactivity via the mobilization of innate helper cells in the lung. Nanotoxicology 7(6), 1070–1081 (2013).
  Medline CASGoogle Scholar
• 22 Shi YH, Shi GC, Wan HY et al. Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with allergic asthma. Chin. Med. J. (Engl). 124(13), 1951–1956 (2011).
  Medline CASGoogle Scholar
• 23 Carneiro ER, Xavier RA, De Castro MA et al. Electroacupuncture promotes a decrease in inflammatory response associated with Th1/Th2 cytokines, nitric oxide and leukotriene B4 modulation in experimental asthma. Cytokine 50(3), 335–340 (2010).
  Medline CASGoogle Scholar
• 24 Van Schaik SM, Obot N, Enhorning G et al. Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice. J. Med. Virol. 62(2), 257–266 (2000).
  Medline CASGoogle Scholar
• 25 Lloyd CM, Hessel EM. Functions of T cells in asthma: more than just T(H)2 cells. Nat. Rev. Immunol. 10(12), 838–848 (2010).
  Medline CASGoogle Scholar
• 26 Schmitz J, Owyang A, Oldham E et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23(5), 479–490 (2005).
  Medline CASGoogle Scholar
• 27 Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 10(2), 103–110 (2010).
  Medline CASGoogle Scholar
• 28 Mirchandani AS, Salmond RJ, Liew FY. Interleukin-33 and the function of innate lymphoid cells. Trends Immunol. 33(8), 389–396 (2012).
  Medline CASGoogle Scholar
• 29 Salmond RJ, Mirchandani AS, Besnard AG et al. IL-33 induces innate lymphoid cell-mediated airway inflammation by activating mammalian target of rapamycin. J. Allergy Clin. Immunol. 130(5), 1159–1166 (2012).
  Medline CASGoogle Scholar
• 30 Yasuda K, Muto T, Kawagoe T et al. Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc. Natl Acad. Sci. USA 109(9), 3451–3456 (2012).
  Medline CASGoogle Scholar
• 31 Molofsky AB, Nussbaum JC, Liang HE et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J. Exp. Med. 210(3), 535–549 (2013).
  Medline CASGoogle Scholar
• 32 Liu B, Kimura Y. Respiratory syncytial virus protects against the subsequent development of Japanese cedar pollen-induced allergic responses. J. Med. Virol. 79(10), 1600–1605 (2007).
  Medline CASGoogle Scholar
• 33 Saravia J, You D, Shrestha B et al. Respiratory syncytial virus disease is mediated by age-variable IL-33. PLoS Pathog. 11(10), e1005217 (2015).
  MedlineGoogle Scholar